Efficacy and Safety Study to Evaluate MT-6548 in Peritoneal Dialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan

NCT03402386 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia; Peritoneal Dialysis Dependent Chronic Kidney Disease

Interventions

DRUG: MT-6548

Sponsor

Tanabe Pharma Corporation